Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Infiuss Health
AddedMar 17, 2024
UpdatedJul 2, 2026
Infiuss Health

Infiuss Health

Seed

Marketplace connecting patients to medical research & SAAS for African clinical trials.

Founded
2021
Accelerator
Y Combinator logoY CombinatorS21
Overview
Compare
Fundraising
Employees
Website

Infiuss Health, founded with the mission to accelerate medical research, focuses on creating a seamless connection between patients and researchers. The company offers a unified platform that facilitates patient recruitment, specimen sourcing, and clinical data aggregation. By building a community of patients eager to contribute to medical research, Infiuss Health aims to streamline the research process for life sciences companies and researchers, particularly in the context of African clinical trials.

Notable figures affiliated with Infiuss Health include its founders and key investors who have supported its growth. The company has achieved significant milestones, such as establishing a robust patient community and providing scalable solutions for clinical research. Its impact is evident in the enhanced efficiency and scalability it brings to human subject-based research, making it a pivotal player in the medical research landscape.

Infiuss Health - Similar Companies

SubjectWell logo

SubjectWell

subjectwell.com

Power Life Science logo

Power Life Science

withpower.com

1nHealth logo

1nHealth

1nhealth.com

FindMeCure logo

FindMeCure

findmecure.com

Paradigm logo

Paradigm

paradigm.inc

Humine logo

Humine

huminelabs.com

Leapcure logo

Leapcure

leapcure.com

MedVector logo

MedVector

medvector.com

Novelcare logo

Novelcare

selectiq.com

High Enroll logo

High Enroll

highenroll.org

PicnicAI logo

PicnicAI

picnichealth.com

Crescendo Health logo

Crescendo Health

crescendo.health

H1 logo

H1

h1.co

ResearchWe logo

ResearchWe

PatientEvolution logo

PatientEvolution

Infiuss Health - Quick Facts

Who are Infiuss Health's competitors?

Companies similar to Infiuss Health include SubjectWell, Power Life Science, 1nHealth and FindMeCure.

When was Infiuss Health founded?

Infiuss Health was founded in 2021.

When was Infiuss Health's last funding round?

Infiuss Health's most recent funding round was for $125k (USD) in January 2021.

How much has Infiuss Health raised to-date?

As of Jan 1, 2021, Infiuss Health has raised a total of $125k (USD).

How many employees does Infiuss Health have?

Infiuss Health has 4 employees as of Apr 14, 2024.

Infiuss Health - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Analytics
Model
  • Marketplace
  • Platform
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
  • Small Business
Main Product
  • Data
  • Patient Recruitment
Tags
  • Healthtech
  • SaaS